Literature DB >> 15194842

Lack of evidence of encephalopathy related to pertussis vaccine: active surveillance by IMPACT, Canada, 1993-2002.

Dorothy L Moore1, Nicole Le Saux, David Scheifele, Scott A Halperin.   

Abstract

To assess whether pertussis-containing vaccines cause encephalitis or encephalopathy, the IMPACT network of Canadian pediatric centers screened more than 12,000 admissions for neurologic disorders between 1993 and 2002. Seven cases of encephalopathy began within 7 days after pertussis vaccination, but a more likely cause was found in each instance. No attributable case followed administration of >6.5 million doses of vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15194842     DOI: 10.1097/01.inf.0000130075.56368.02

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  7 in total

1.  IMPACT after 17 years: Lessons learned about successful networking.

Authors: 
Journal:  Paediatr Child Health       Date:  2009-01       Impact factor: 2.253

2.  IMPACT after 17 years: Lessons learned about successful networking.

Authors: 
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 3.  Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies.

Authors:  Seema Mattoo; James D Cherry
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors:  Jennifer L Liang; Tejpratap Tiwari; Pedro Moro; Nancy E Messonnier; Arthur Reingold; Mark Sawyer; Thomas A Clark
Journal:  MMWR Recomm Rep       Date:  2018-04-27

5.  Safety Surveillance of Diphtheria and Tetanus Toxoids and Acellular Pertussis (DTaP) Vaccines.

Authors:  Pedro L Moro; Silvia Perez-Vilar; Paige Lewis; Marthe Bryant-Genevier; Hajime Kamiya; Maria Cano
Journal:  Pediatrics       Date:  2018-06-04       Impact factor: 7.124

6.  Is SARS-CoV-2 vaccination safe and effective for elderly individuals with neurodegenerative diseases?

Authors:  Yan Shi; Minna Guo; Wenjing Yang; Shijiang Liu; Bin Zhu; Ling Yang; Chun Yang; Cunming Liu
Journal:  Expert Rev Vaccines       Date:  2021-04-12       Impact factor: 5.217

7.  Active Surveillance of Adverse Events Following Human Papillomavirus Vaccination: Feasibility Pilot Study Based on the Regional Health Care Information Platform in the City of Ningbo, China.

Authors:  Zhike Liu; Liang Zhang; Yu Yang; Ruogu Meng; Ting Fang; Ying Dong; Ning Li; Guozhang Xu; Siyan Zhan
Journal:  J Med Internet Res       Date:  2020-06-01       Impact factor: 5.428

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.